BlackBarn Capital Partners LP In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), BlackBarn Capital Partners LP reported 17 stock positions worth $402.2 million . Its top holding was Roivant Sciences (ROIV) at 17.6% of the portfolio, followed by Privia Health (PRVA, 10.1% ) and Diversified Healthcare Trust (DHC, 9.4% ). Compared with Q1 2026, it opened 5 new positions, sold out of 2, added to 3 and reduced 5. The biggest buy was a new position in Unitedhealth (UNH) and the biggest sale an exit from Veeco Instruments (VECO).
Location NEW YORK, NY
CIK 0002010204
Portfolio Value $402.2M (Q2 2026) Holdings 17 stocks · $402.2M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2026 ROIV Roivant Sciences Ltd. 2,000,000 $70.8M Reduce -12.5% PRVA Privia Health Group Inc. 1,585,000 $40.8M No change DHC Diversified Healthcare Trust 4,075,000 $37.9M Reduce -15.3% NEE Nextera Energy Inc. 335,000 $29.4M No change NIQ Niq Global Intelligence PLC 2,903,862 $27.2M Add +40.0% UNH Unitedhealth Group Inc. 65,000 $27.0M New NXPI NXP Semiconductors NV 90,000 $25.3M Add +50.0% VKTX Viking Therapeutics Inc. 600,000 $23.4M Reduce -3.5% MH McGraw Hill Inc. 2,450,000 $23.2M Add +17.3% AMRX Amneal Pharmaceuticals Inc. 1,300,000 $22.5M Reduce -21.2% VG Venture Global Inc. Class A 1,750,000 $19.5M New AZUL Azul SA-Spon ADR 1,684,188 $15.1M New OXY Occidental Petroleum Corp. 250,000 $12.1M New ABUS Arbutus Biopharma Corp. 2,500,000 $12.0M No change CRC California Resources Corp. 175,000 $9.3M New CCOI Cogent Communications Holdin 250,000 $3.5M Reduce -50.0% SEAT Vivid Seats Inc. Class A 500,000 $3.3M No change
Options reported separately and not counted above: SPY puts ($597.4M), OSCR puts ($49.9M), UNH calls ($41.6M), RMD puts ($39.0M), VG calls ($33.4M), WRBY puts ($12.1M), VKTX calls ($9.8M).
Portfolio Sells Q1 2026 → Q2 2026 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▲ VECO Veeco Instruments Inc. Sold out 0.00% −10.19 GBTG Global Business Travel Group Sold out 0.00% −3.36 CCOI Cogent Communications Holdin Reduce -50.0% 0.86% −1.97 ROIV Roivant Sciences Ltd. Reduce -12.5% 17.60% −1.45 AMRX Amneal Pharmaceuticals Inc. Reduce -21.2% 5.60% −0.58 VKTX Viking Therapeutics Inc. Reduce -3.5% 5.82% −0.26 DHC Diversified Healthcare Trust Reduce -15.3% 9.42% −0.19
Portfolio Buys Q1 2026 → Q2 2026 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▼ UNH Unitedhealth Group Inc. New 6.72% +6.72 VG Venture Global Inc. Class A New 4.84% +4.84 AZUL Azul SA-Spon ADR New 3.76% +3.76 OXY Occidental Petroleum Corp. New 3.02% +3.02 NXPI NXP Semiconductors NV Add +50.0% 6.29% +2.74 CRC California Resources Corp. New 2.30% +2.30 NIQ Niq Global Intelligence PLC Add +40.0% 6.75% −0.35 MH McGraw Hill Inc. Add +17.3% 5.77% −2.84
Options Activity Q1 2026 → Q2 2026 Security Type Change vs Q1 2026 Underlying Shares Value ▼ EWZ iShares MSCI Brazil ETF put Sold out 5,250,000 $201.5Mbefore exit OSCR Oscar Health Inc. Class A put New 1,750,000 $49.9M AAL American Airlines Group Inc. put Sold out 4,000,000 $43.0Mbefore exit UNH Unitedhealth Group Inc. call New 100,000 $41.6M RMD Resmed Inc. put Reduce -50.0% 200,000 $39.0M VG Venture Global Inc. Class A call New 3,000,000 $33.4M PLTR Palantir Technologies Inc. Class A put Sold out 175,000 $25.6Mbefore exit WRBY Warby Parker Inc. Class A put Reduce -60.0% 400,000 $12.1M VKTX Viking Therapeutics Inc. call New 250,000 $9.8M CCOI Cogent Communications Holdin put Sold out 500,000 $9.4Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 17 $402.2M ROIV, PRVA, DHC, NEE, NIQ Q1 2026 14 $332.4M ROIV, VECO, PRVA, DHC, NEE Q4 2025 11 $278.9M ROIV, DHC, PRVA, NIQ, NEE Q3 2025 15 $306.4M ROIV, PRVA, DHC, NXT, AMRX Q2 2025 20 $301.8M ROIV, AMRX, ACLS, DHC, MOH Q1 2025 18 $292.8M ROIV, UNH, MOH, AMRX, ACLS Q4 2024 15 $254.1M ROIV, UNH, MOH, TEVA, AMRX Q3 2024 18 $230.1M ROIV, MOH, AMRX, DHC, T Q2 2024 17 $194.0M ROIV, UNH, MOH, AMRX, BRBS Q1 2024 21 $173.0M ROIV, MOH, UNH, CHRD, CF